packageBezlotoxumab

bezlotoxumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Bezlotoxumab, a monoclonal antibody, is used to help prevent recurrence of Clostridioides difficile infection (pseudomembranous enterocolitis). It is approved and authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q4900370 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:bezlotoxumab
ATC codes:J06BB21, J06BC03
DrugBank:DB13140
Wikidata:Q4900370
molar mass:148200 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown